Ernexa Therapeutics Inc. (ERNA): Going concern doubt
Severity scores the disclosed filing signal, not a judgment about the company or its securities.
What was disclosed
not qualified or modified as to uncertainty, audit scope, or accounting principles, except that, the reports included an explanatory paragraph describing that substantial doubt was raised as to the Company’s ability to continue as a going concern.
Why it matters
A going-concern disclosure reflects substantial doubt about the company's ability to continue operating.